Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pulmonx (LUNG) Revenue (2019 - 2025)

Pulmonx has reported Revenue over the past 7 years, most recently at $21.5 million for Q3 2025.

  • Quarterly Revenue rose 5.47% to $21.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $91.7 million through Sep 2025, up 15.59% year-over-year, with the annual reading at $83.8 million for FY2024, 22.01% up from the prior year.
  • Revenue was $21.5 million for Q3 2025 at Pulmonx, down from $23.9 million in the prior quarter.
  • Over five years, Revenue peaked at $23.9 million in Q2 2025 and troughed at $9.2 million in Q1 2021.
  • The 5-year median for Revenue is $17.2 million (2023), against an average of $17.0 million.
  • Year-over-year, Revenue skyrocketed 232.24% in 2021 and then increased 1.82% in 2022.
  • A 5-year view of Revenue shows it stood at $13.7 million in 2021, then grew by 12.53% to $15.4 million in 2022, then increased by 24.98% to $19.3 million in 2023, then grew by 23.28% to $23.8 million in 2024, then fell by 9.52% to $21.5 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Revenue are $21.5 million (Q3 2025), $23.9 million (Q2 2025), and $22.5 million (Q1 2025).